Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today that Shaperon will commence the Phase 2b Part 2 of its clinical trial for NuGel, a first-in-class inflammasome inhibitor designed ...

Sam Ward, P.T., Ph.D., professor in the Departments of Orthopaedic Surgery, Radiology and Bioengineering at the University of ...

The U.S. stock market is continuing to tumble amid President Trump's tariffs war and fears of a potential recession. Newsweek ...

Digital physical therapy startup Hinge Health filed its IPO prospectus with the SEC on Monday. The company's revenue jumped 33% in 2024 to $390 million. Hinge Health uses software to help patients ...

Physics professor J. Ping Liu helps boost nation’s energy security and advance toward a world-class magnet research hub ...

Aspiring physical therapists need all the resources they can get to prepare them for career success. Read this guide to see ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.